Heran Darwin Lab - Microbiology
Heran Darwin Ph.D.
Professor, Department of Microbiology
Medical Science Building , Room 236
550 First Avenue , New York NY 10016
Office: (212) 263-2624
Fax: (212) 263-8276
Mycobacterium tuberculosis, microbial pathogenesis; molecular biology; proteasome, pupylation, Pup, copper, transcriptional regulation, proteolysis.
1992-1999 PhD, University of California, Los Angeles
1999-2001: Washington University, School of Medicine
2003: Instructor of Microbiology and Immunology
Course Director (Advanced Topics in Microbial Pathogenesis)
ICAAC Young Investigator Award (2006)
The Tuberculosis Proteasome and Pathogenesis
The pathogen and the disease. Tuberculosis is one of the leading causes of death in the world, killing about 2 million people per year. Nearly one-third of the world is infected with Mtb, which is a rod shaped bacterium that persists in phagocytic cells in the lungs of humans. Although healthy individuals usually control Mtb growth, immunosuppression due to a variety of causes can result in increased bacterial replication and the onset of symptoms. Antibiotic therapy is prolonged (6-9 months) and the failure to comply with treatment can lead to the development of multi-drug and extensively drug resistant strains. New drugs to treat tuberculosis are urgently needed, thus researchers are working to identify activities in Mtb that can be targeted.
The task of finding new drugs and drug targets is hindered by the fact that Mtb is dangerous and slow growing, requiring 2-3 weeks to form colonies on solid media. Furthermore, due to the highly infectious nature of the pathogen, all work must be performed in a biosafety level-3 facility. Taken together, Mtb is one of the most significant and challenging organisms to study.
Mycobacterial resistance to host defenses: the bacterial proteasome. Mtb proteasome activity is required virulence in mice, linking protein degradation to pathogenesis. Proteolysis by the Mtb proteasome requires the 20S proteasome core protease, Pup (prokaryotic ubiquitin-like protein), Mpa (Mycobacterium proteasomal ATPase), PafA (proteasome accessory factor A), and Dop (deamidase of Pup). The 20S core is a barrel shaped chamber with proteolytic activity. Mpa forms hexamers with ATPase activity similar to eukaryotic proteasomal ATPases, and is thought to cap the base of the 20S core. Dop and PafA are required for the conjugation of Pup to proteins to target them to the proteasome. Importantly, 20S core, mpa, dop, and pafA mutants cannot cause lethal infections in mice. Although it is clear that proteasome activity is required for the pathogenesis of Mtb, we do not fully understand why.
Bacterial ubiquitin-proteasome system. Small protein modifiers like ubiquitin and SUMO are extensively studied in eukaryotes but had not been found in prokaryotes until relatively recently. Pup is the first protein-to-protein post-translational modifier to be identified in prokaryotes. The Mtb enzymes involved in "pupylation" share little to no structural or enzymatic features with the eukaryotic ubiquitin systems.
M. tuberculosis and copper. We recently identified a copper-responsive regulon that is dependent on proteasome function and is unique to pathogenic Mycobacterium species. RicR (regulated in copper repressor) regulates five promoters that drive the expression of several genes whose functions are largely unknown. We are currently working to characterize the function of several gene products of this regulon. We are also trying to understand why a pathogen like Mtb, which lives exclusively in humans, needs to respond to copper. Data from several labs suggest that vertebrate hosts use copper to battle invading pathogens, and bacteria have developed mechanisms to resist this host defense.
Shi X, Festa RA, loerger TR, Butler-Wu S, Sacchettini JC, Darwin KH, Samanovic MI.
MBio. 2014 Feb 18;r(1). pii: e00876-13. doi:10.1128/mBio.00876-13.
Samanovic MI, Li H, Darwin KH.
Subcell Biochem. 2013;66:267-95.
Samanovic MI, Ding C, Thiele DJ, Darwin KH.
2012.Cell Host Microbe. 11:106-15.
Merkx, R.K.E. Burns, P. Slobbe,F. El-Oualid, D. El-Atmioui, K.H. Darwin, H. Ovaa.
2012. ChemBioChem. 13:2056-60.
Burns, K.E., F. McAllister, C. Schwerdtfeger, J. Mintseris, F. Cerda-Maira, E.E. Noens, M. Wilmanns, S.R. Hubbard, F. Melandri, H. Ovaa, S.P. Gygi, and K.H. Darwin.
2012. J. Biol. Chem. In press.
Cerda-Maira, F., F. McAllister, N.J. Bode, K.E. Burns, S.P. Gygi, and K.H. Darwin.
2011. EMBO Reports. 12:863-70.
Festa RA, Jones MB, Butler-Wu S, Sinsimer D, Gerads R, Bishai WR, Peterson SN, Darwin KH.
Mol Microbiol. 2011 Jan;79(1):133-48.
Wang T, Darwin KH, Li H.
Nat Struct Mol Biol. 2010 Nov;17(11):1352-7.
Burns KE, Cerda-Maira FA, Wang T, Li H, Bishai WR, Darwin KH.
Mol Cell. 2010 Sep 10;39(5):821-7.
Cerda-Maira FA, Pearce MJ, Fuortes M, Bishai WR, Hubbard SR, Darwin KH.
Mol Microbiol. 2010 Sep;77(5):1123-35.
Burns KE, Pearce MJ, Darwin KH.
J Bacteriol. 2010 Jun;192(11):2933-5.
Festa RA, McAllister F, Pearce MJ, Mintseris J, Burns KE, Gygi SP, Darwin KH.
PLoS One. 2010 Jan 6;5(1):e8589.
Wang T, Li H, Lin G, Tang C, Li D, Nathan C, Darwin KH, Li H.
Structure. 2009 Oct 14;17(10):1377-85.
Chen X, Solomon WC, Kang Y, Cerda-Maira F, Darwin KH, Walters KJ.
J Mol Biol. 2009 Sep 11;392(1):208-17.
Nat Rev Microbiol. 2009 Jul;7(7):485-91
Pearce MJ, Mintseris J, Ferreyra J, Gygi SP, Darwin KH.
Science. 2008 Nov 14;322(5904):1104-7.
Festa RA, Pearce MJ, Darwin KH.
J Bacteriol. 2007 Apr;189(8):3044-50.
Xiaoshan "Shirely" Shi
Marie Samanovic-Golden, PhD
Ricky Festa, PhD
Susan Butler-Wu, PhD
Daniel Sinsimer, PhD
Francisca Cerda-Maira, PhD
Kristin Burns, PhD